LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Spine/ISASS Issues NeuroStim Guidelines
Spine

ISASS Issues NeuroStim Guidelines

September 18, 2023 2 min read Premium comments

Advertisement

ISASS Issues NeuroStim Guidelines
Courtesy of ISASS
#ISASSSecondary#lowbackpain#neurostimulation

The International Society for the Advancement of Spine Surgery (ISASS) has just issued a comprehensive set of guidelines for treating low back pain patients with restorative neurostimulation therapies.

The new guideline cover:

  • The definition of mechanical chronic low back pain
  • How it presents clinically
  • The prevalence and nuance of low back pain
  • The critical role muscles play in generating low back pain
  • How mechanism of action for restorative neurostimulation
  • Patient selection for neurostim treatment
  • Clinical evidence for neurostimulation
  • Reimbursement landscape including the relevant ICD-10 codes?
  • Costs, direct and indirect.

The authors of the study were:

  • Morgan Lorio, M.D., FACS with the Orthopedic Laser and Spine Center at LSU,
  • Kai-Uwe Lewandrowski, M.D., with the Center for Advanced Spinal Surgery in Tucson,
  • Domagoj Coric, M.D., neurosurgeon, Carolina Neurosurgery and Spine Associates,
  • Frank Phillips, M.D., Director of Spine Surgery at Rush Medical and
  • Christopher I. Shaffrey, M.D., neurosurgeon at the Duke Spine Center

These guidelines come at a most propitious moment. Interventional pain management is, perhaps, the fastest growing sector in the treatment of back pain. Caregivers, notably surgeons and interventional pain specialists, need a comprehensive and authoritative study to help guide the use of these interesting and promising therapies.

For sure, chronic low back pain (LBP) is a diverse and often debilitating experience for a significant proportion of the U.S. population.

Conservative management is step one and remains the predominant care pathway. However, for many patients, conservative care falls too short of symptom relief.

Restorative neurostimulation is a new and promising technique for patients who have exhausted traditional care paradigms.

According to the authors: “Restorative neurostimulation for chronic mechanical LBP is supported by several clinical studies that show robust and durable clinical effects over the pretreatment condition.”

Advertisement

“The totality of evidence suggests that in a well-selected patient population who have exhausted conventional care paradigms, the potential benefits outweigh the risks and costs. These patients tend to be exposed to multiple therapies with limited durability, resulting in a continuous cycle of high-cost health care utilization.”

“Restorative neurostimulation should be considered for clinically appropriate patients who have exhausted reasonable conservative approaches.”

To read the guidelines yourself, here is a link.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy